TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+9.48%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(-24%)
Cap. Flow
-$89.9M
Cap. Flow
% of AUM
-37.63%
Top 10 Holdings %
Top 10 Hldgs %
77.92%
Holding
44
New
11
Increased
6
Reduced
8
Closed
16
Top Buys
| 1 |
Cigna
CI
|
$12M |
| 2 |
Aldeyra Therapeutics
ALDX
|
$9.27M |
| 3 |
Pfizer
PFE
|
$7.94M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.16M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$6.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$26.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$24.7M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
$14.6M |
| 4 |
Johnson & Johnson
JNJ
|
$13.7M |
| 5 |
Humana
HUM
|
$10.8M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $42.2M | 13.83% | 75,627 +10,922 | +17% | +$6.1M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24.1M | 7.9% | 257,764 -35,662 | -12% | -$3.34M |
|
3
Medtronic
MDT
$119B
| $22.9M | 7.5% | 184,680 -54,964 | -23% | -$6.82M |
|
|
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
| $22.4M | 7.33% | 425,671 +25,829 | +6% | +$1.36M |
|
5
Jazz Pharmaceuticals
JAZZ
$7.75B
| $15.9M | 5.2% | 89,370 -21,012 | -19% | -$3.73M |
|
6
Protagonist Therapeutics
PTGX
$3.67B
| $15.3M | 5.02% | 341,650 +84,564 | +33% | +$3.8M |
|
|
7
Johnson & Johnson
JNJ
$427B
| $14.1M | 4.62% | 85,596 -83,038 | -49% | -$13.7M |
|
|
8
Cigna
CI
$80.3B
| $12M | 3.93% | +50,699 | New | +$12M |
|
|
9
Aldeyra Therapeutics
ALDX
$351M
| $9.27M | 3.03% | +818,025 | New | +$9.27M |
|
|
10
Pfizer
PFE
$141B
| $7.94M | 2.6% | +202,692 | New | +$7.94M |
|
11
Evolus
EOLS
$494M
| $6.29M | 2.06% | 496,826 +415,801 | +513% | +$5.26M |
|
|
ITCI
12
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.16M | 2.01% | +150,783 | New | +$6.16M |
|
13
Celldex Therapeutics
CLDX
$1.47B
| $5.86M | 1.92% | 175,305 -21,367 | -11% | -$714K |
|
|
14
Humana
HUM
$36.5B
| $5.01M | 1.64% | 11,305 -24,388 | -68% | -$10.8M |
|
15
Edwards Lifesciences
EW
$47.8B
| $5M | 1.64% | +48,267 | New | +$5M |
|
16
Moderna
MRNA
$9.37B
| $4.51M | 1.48% | +19,193 | New | +$4.51M |
|
|
EGRX
17
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.06M | 1.33% | +94,922 | New | +$4.06M |
|
|
MREO
18
Mereo BioPharma
MREO
$272M
| $3.97M | 1.3% | +1,253,729 | New | +$3.97M |
|
|
SNCE
19
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $2.7M | 0.88% | 269,872 -30,128 | -10% | -$301K |
|
|
AVDL
20
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.11M | 0.69% | 313,795 +153,539 | +96% | +$1.03M |
|
21
argenx
ARGX
$43.6B
| $1.93M | 0.63% | +6,408 | New | +$1.93M |
|
22
Cyclacel Pharmaceuticals
CYCC
$18.4M
| $1.86M | 0.61% | 313,331 +19,912 | +7% | +$118K |
|
23
Femasys
FEMY
$11.6M
| $1.53M | 0.5% | +188,753 | New | +$1.53M |
|
|
BLU
24
DELISTED
BELLUS Health Inc.
BLU
| $1.17M | 0.38% | 375,520 -4,717 | -1% | -$14.7K |
|
|
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $611K | 0.2% | +96,820 | New | +$611K |
|